ArticleProceedings of the National Academy of Sciences of the United States of America2017

Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.

Frederic Morvan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.